CALL/MERCK & CO./180/0.1/17.01.25 Stock

Warrant

DE000GZ98XV1

Real-time BOERSE MUENCHEN 10:26:35 2024-07-01 EDT
0.045 EUR +4.65% Intraday chart for CALL/MERCK & CO./180/0.1/17.01.25
Current month+38.71%
1 month+126.32%
Date Price Change
24-07-01 0.045 +4.65%
24-06-28 0.043 +48.28%
24-06-27 0.029 -21.62%
24-06-26 0.037 -27.45%
24-06-25 0.051 +70.00%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 10:26 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Goldman Sachs
WKN GZ98XV
ISINDE000GZ98XV1
Date issued 2023-02-24
Strike 180 $
Maturity 2025-01-17 (200 Days)
Parity 10 : 1
Emission price 0.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.118
Lowest since issue 0.008
Spread 0.049
Spread %53.85%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8 USD
Average target price
142.7 USD
Spread / Average Target
+15.25%
Consensus